Stay updated on Eribulin + Pembrolizumab in Soft Tissue Sarcomas Clinical Trial
Sign up to get notified when there's something new on the Eribulin + Pembrolizumab in Soft Tissue Sarcomas Clinical Trial page.

Latest updates to the Eribulin + Pembrolizumab in Soft Tissue Sarcomas Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedRecruitment status now shows 'No longer looking for participants' and new help sections (How to Read a Study Record, Common Questions, How to Join a Study) were added to assist potential participants. The revision tag was updated to v3.6.0 and the Intervention/Treatment header was reformatted (Intervention / Treatment -> Intervention/Treatment).SummaryDifference0.4%

- Check20 days agoChange DetectedA new page revision tag 'v3.5.5' appears, replacing the previous 'v3.5.4'. This marks a small update to the page's revision state and does not change the study content.SummaryDifference0.1%

- Check41 days agoChange DetectedRevision: v3.5.4 now appears on the page, replacing the previous v3.5.3.SummaryDifference0.1%

- Check63 days agoChange DetectedThe page footer has an updated software/UI revision label from v3.5.2 to v3.5.3.SummaryDifference0.1%

- Check70 days agoChange DetectedRevision label updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check91 days agoChange DetectedAdded the MeSH term Malignant fibrous histiocytoma to the study's indexing terms.SummaryDifference0.1%

Stay in the know with updates to Eribulin + Pembrolizumab in Soft Tissue Sarcomas Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Eribulin + Pembrolizumab in Soft Tissue Sarcomas Clinical Trial page.